Olathe-based Metactive lands $1.5M, two medical patents

March 21, 2017  |  Meghan LeVota

Olathe-based medical device company Metactive released a pair of positive announcements for the firm.

Dr. Nick Franano

In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.

Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.

CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.

“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”

Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.

Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.

Tagged ,
Featured Business
    Featured Founder
      [adinserter block="4"]

      2017 Startups to Watch

        stats here

        Related Posts on Startland News

        High-tech car showroom parks in Crossroads

        By Tommy Felts | July 21, 2015

        The days of pushy, plaid-suited car salesmen is over at a new dealership teeming with technology in Kansas City’s Crossroads Arts District. Luxury car dealer Pure Pursuit Automotive recently set up shop in one of Kansas City’s trendiest districts, incorporating such technology as holographic attendants and personal tablets. Those technologies and others aim to create…

        Kittrell: 5 frustrations for non-technical founders

        By Tommy Felts | July 21, 2015

        You’ve got a great idea for an app — the kind that keeps you up at night. But you’ve never worked on a software project before and have no idea what you’re in for. Sound familiar? Here’s a list of common frustrations I see from my non-technical clients. 1. Scope creep No, it’s not a…

        Gallery: Lean Lab fellows set to disrupt KC education

        By Tommy Felts | July 20, 2015

        Already improving education for about 2,400 area students, the Lean Lab recently set loose another group of innovators hoping to transform Kansas City education. The Kansas City-based education innovation incubator on Friday held its Launch Day, the culminating event of its incubator fellowship. The incubator conducted a five-week ideation program that assisted 10 fellows building…

        Applications open for Missouri tech funding

        By Tommy Felts | July 20, 2015

        Ready your typing fingers, entrepreneurs. The Missouri Technology Corporation recently opened applications for its IDEA Fund, a program that will match other capital investments in high-growth tech companies. The MTC, a public-private organization that makes investments in Missouri tech companies, is currently accepting applications for four of its IDEA programs, three of which are tailored…